MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Neoplasms, Bone Tissue

(UMLS:C0206639)

Definition:: Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones.
UMLS ID:: C0206639
MeSH ID:: D018213

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.565.575

Synonym(s)

Neoplasms, Bone Tissue

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Cyclophosphamide	278643	CTD
2	Doxorubicin	278643	CTD
3	Vincristine	278643	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Myxoma	48.4%
2	Neoplasms, Fibrous Tissue	48.4%
3	Chondroma	48.4%
4	Enchondroma	48.4%
5	Chondrosarcoma	47.3%
6	synovial sarcoma	47.3%
7	Clear Cell Sarcoma of Soft Tissue	47.3%
8	Fibrosarcoma	39%
9	fibroma	36%
10	Fibromatosis	36%
11	Chondromatosis	36%
12	Malignant Fibrous Histiocytoma	34.9%
13	Sarcoma	34.4%
14	Dermatofibrosarcoma	31%
15	Dermatofibrosarcoma Protuberans	31%
16	leiomyosarcoma	30.1%
17	liposarcoma	30.1%
18	Angiomyolipoma	30.1%
19	Alveolar Soft Part Sarcoma	30.1%
20	Fibromatosis, Aggressive	29.9%
21	Fibromatosis, Abdominal	29.9%
22	Adenofibroma	26.4%
23	Fibroadenoma	26.4%
24	leukemia	25.4%
25	Neoplasms, Germ Cell and Embryonal	25.4%
26	Neoplasms, Glandular and Epithelial	25.4%
27	Germ Cell Cancer	25.4%
28	Carcinosarcoma	25%
29	Hemangiosarcoma	25%
30	lymphangiosarcoma	25%
31	Mastocytosis	25%
32	Gastrointestinal Stromal Tumors	24.6%
33	Mastocytoma	24.3%
34	Mastocytosis, Systemic	24.1%
35	Giant Cell Tumor of Bone	23.9%
36	Phyllodes Tumor	22.6%
37	Lipoma	22.6%
38	Myoma	22.6%
39	Angiolipoma	22.6%
40	Myelolipoma	22.6%
41	Smooth Muscle Tumor	22.6%
42	Desmoplastic Small Round Cell Tumor	22.6%
43	Rhabdomyosarcoma	22.3%
44	Sarcoma, Myeloid	21.5%
45	Neuroectodermal Tumors	19.8%
46	Alveolar rhabdomyosarcoma	18.5%
47	Neurofibrosarcoma	17.9%
48	Carcinoma 256, Walker	17.7%
49	Neoplasms, Neuroepithelial	17.1%
50	Gliomatosis cerebri	17.1%
51	Histiocytic Disorders, Malignant	16.9%
52	Rhabdomyoma	16.8%
53	Hamartoma	16.4%
54	Neoplasms, Hormone-Dependent	16.4%
55	Neoplasms, Multiple Primary	16.4%
56	Paraneoplastic Syndromes	16.4%
57	Precancerous Conditions	16.4%
58	Neoplasms, Second Primary	16.4%
59	Sarcoma, Experimental	15.7%
60	Dupuytren Contracture	15.5%
61	Urticaria Pigmentosa	15.2%
62	Osteosarcoma	15%
63	Adenoma	14.8%
64	Ameloblastoma	14.8%
65	Angiokeratoma	14.8%
66	Carcinoma	14.8%
67	Chordoma	14.8%
68	Hemangioma	14.8%
69	hemangiopericytoma	14.8%
70	Lymphangioma	14.8%
71	Mesenchymoma	14.8%
72	Nevus	14.8%
73	Teratoma	14.8%
74	Hepatoblastoma	14.8%
75	Mixed Tumor, Mullerian	14.8%
76	Germinoma	14.8%
77	Teratocarcinoma	14.8%
78	Angiofibroma	14.8%
79	Epithelioma	14.8%
80	Sarcoma 180	14.6%
81	melanoma	14.5%
82	Basal cell carcinoma	12.9%
83	Carcinoma, Papillary	12.9%
84	Squamous cell carcinoma	12.9%
85	Craniopharyngioma	12.9%
86	Cystadenoma	12.9%
87	Mesothelioma	12.9%
88	Neuroectodermal Tumor, Melanotic	12.9%
89	Neuroendocrine Tumors	12.9%
90	Lymphangioleiomyomatosis	12.9%
91	Carcinoma, Basal Cell	12.9%
92	Meningioma	12.7%
93	Lymphoma	12.6%
94	Endometrial Stromal Sarcoma	12.5%
95	Carcinoma, Ehrlich Tumor	12.2%
96	Dermoid Cyst	12.2%
97	Carcinoma, Lewis Lung	12.2%
98	Leukemia, Plasma Cell	12.2%
99	Adenoma, Acidophil	12%
100	Ganglioneuroma	12%
101	Glioma	12%
102	Malignant Glioma	12%
103	Trophoblastic Neoplasms	11.8%
104	Composite Lymphoma	11.8%
105	Leukemia, Experimental	11.7%
106	Cystadenocarcinoma	11.2%
107	Mucoepidermoid Carcinoma	11.2%
108	Medulloblastoma	10.9%
109	Cyst	10.8%
110	Neoplastic Processes	10.8%
111	Neoplastic Syndromes, Hereditary	10.8%
112	Pregnancy Complications, Neoplastic	10.8%
113	Carcinoid Tumor	10.8%
114	Neurilemmoma	10.8%
115	Hutchinson's Melanotic Freckle	10.8%
116	Melanoma, Amelanotic	10.8%
117	Neoplasms, Experimental	10.6%
118	Melanoma, Experimental	10%
119	Plasmacytoma	9.9%
120	Malignant histiocytosis	9.8%
121	Leukemia L1210	9.8%
122	Leukemia P388	9.8%
123	Histiocytic sarcoma	9.8%
124	Acanthoma	9.8%
125	Adenocarcinoma	9.7%
126	Carcinoma in Situ	9.7%
127	Carcinoma, Transitional Cell	9.7%
128	Dysgerminoma	9.7%
129	Hemangioendothelioma	9.7%
130	Neuroma	9.7%
131	Papilloma	9.7%
132	Pseudomyxoma Peritonei	9.7%
133	Seminoma	9.7%
134	Papillomatosis	9.7%
135	Adenomatosis, Pulmonary	9.7%
136	Adenomatous Polyps	9.7%
137	Carcinoma, Large Cell	9.7%
138	Carcinoma, Small Cell	9.7%
139	Bowen's Disease	9.6%
140	Paraganglioma	9.6%
141	Astrocytoma	9.5%
142	Ependymoma	9.5%
143	oligodendroglioma	9.5%
144	Ganglioglioma	9.5%
145	gliosarcoma	9.5%
146	Anaplastic astrocytoma	9.5%
147	Anaplastic Oligodendroglioma	9.5%
148	Leukemia, Radiation-Induced	9.5%
149	Thymoma	9%
150	Malignant Carcinoid Syndrome	8.9%
151	Choriocarcinoma	8.7%
152	Carcinoma, Lobular	8.7%
153	Abdominal Neoplasms	8.5%
154	Erythroplasia	8.5%
155	Follicular cyst	8.5%
156	Head and Neck Neoplasms	8.5%
157	Mucocele	8.5%
158	Pilonidal Cyst	8.5%
159	Soft Tissue Neoplasms	8.5%
160	Thoracic Neoplasms	8.5%
161	Thyroglossal Cyst	8.5%
162	Synovial Cyst	8.5%
163	Aberrant Crypt Foci	8.5%
164	Glioblastoma	8.3%
165	Neuroblastoma	8.3%
166	Glioblastoma Multiforme	8.3%
167	Pheochromocytoma	7.9%
168	Neoplasms, Radiation-Induced	7.9%
169	Ganglioneuroblastoma	7.7%
170	Multiple Endocrine Neoplasia	7.4%
171	Hodgkin Disease	7.3%
172	Lymphoma, Non-Hodgkin	7.3%
173	Adenoid Cystic Carcinoma	7.2%
174	Adenocarcinoma, Clear Cell	7.2%
175	Cholangiocarcinoma	7.2%
176	Cervical Intraepithelial Neoplasia	7.2%
177	Hemangioblastoma	7.2%
178	Lymphoma, Extranodal NK-T-Cell	7.2%
179	Retinoblastoma	7%
180	Paraneoplastic Encephalomyelitis	6.8%
181	Mammary Neoplasms, Experimental	6.7%
182	Carcinoid Heart Disease	6.5%
183	Leukemia, Myelomonocytic, Chronic	6.5%
184	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	6.5%
185	Lymphomatoid Granulomatosis	6.2%
186	Digestive System Neoplasms	6%
187	Endocrine Gland Neoplasms	6%
188	Eye Neoplasms	6%
189	Nervous System Neoplasms	6%
190	Klatskin Tumor	6%
191	Primary amyloidosis	5.9%
192	Bone neoplasms	5.7%
193	Leukoplakia	5.7%
194	Lymphocele	5.7%
195	Pancreatic Cyst	5.7%
196	Skin Neoplasms	5.7%
197	Hematologic Neoplasms	5.7%
198	Nephroblastoma	5.6%
199	Barrett Esophagus	5.6%
200	Breast Cyst	5.6%
201	Actinic keratosis	5.6%
202	Mediastinal Cyst	5.6%
203	Neoplasm Invasiveness	5.6%
204	Neoplasm Metastasis	5.6%
205	Neoplasm Recurrence, Local	5.6%
206	Parovarian Cyst	5.6%
207	Pericardial Cyst	5.6%
208	Splenic Neoplasms	5.6%
209	Thymic Cyst	5.6%
210	Carcinogenesis	5.6%
211	Myxoid cyst	5.6%
212	Metastasis	5.6%
213	Hepatocellular Adenoma	5.2%
214	Hydatidiform Mole	5.2%
215	Tuberous Sclerosis	5.1%
216	Basal Cell Nevus Syndrome	5.1%
217	Sturge-Weber Syndrome	5%
218	Carcinoma, Pancreatic Ductal	5%
219	Retroperitoneal Neoplasms	4.9%
220	Hemangioma, Cavernous	4.9%
221	Leukemia, T-Cell	4.8%
222	Leukemia, B-Cell	4.8%
223	Mesoblastic Nephroma	4.8%
224	neurofibroma	4.8%
225	Lymphoma, Follicular	4.8%
226	T-Cell Lymphoma	4.8%
227	Mantle cell lymphoma	4.8%
228	Acoustic Neuroma	4.8%
229	Leukemia, Myeloid, Chronic-Phase	4.8%
230	Multiple Endocrine Neoplasia Type 1	4.4%
231	Prolactinoma	4.3%
232	Growth Hormone-Secreting Pituitary Adenoma	4.3%
233	Optic Nerve Glioma	4.3%
234	Waldenstrom Macroglobulinemia	4.2%
235	Multiple Myeloma	4.2%
236	Vipoma	4.2%
237	Corpus Luteum Cyst	4.1%
238	Ovarian Cysts	4.1%
239	Parathyroid Neoplasms	4.1%
240	Peritoneal Neoplasms	4.1%
241	Thyroid Neoplasm	4.1%
242	Thyroid carcinoma	4.1%
243	Liver Neoplasms, Experimental	3.9%
244	granulosa cell tumor	3.7%
245	Carcinoma, Ovarian Epithelial	3.7%
246	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
247	Leukemia, Large Granular Lymphocytic	3.6%
248	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
249	Lymphoma, T-Cell, Cutaneous	3.6%
250	Lymphoma, AIDS-Related	3.6%
251	Enteropathy-Associated T-Cell Lymphoma	3.6%
252	Primary Effusion Lymphoma	3.6%
253	Adenomatous Polyposis Coli	3.5%
254	insulinoma	3.4%
255	Pancreatic Neoplasm	3.4%
256	Choledochal Cyst	3.4%
257	Tracheal Neoplasms	3.4%
258	Mouth Neoplasms	3.4%
259	Central Nervous System Neoplasms	3.4%
260	Vascular Neoplasms	3.4%
261	Thymus Neoplasms	3.4%
262	Genital Neoplasms, Female	3.3%
263	Pancreatic Pseudocyst	3.3%
264	Peutz-Jeghers Syndrome	3.3%
265	Leukoplakia, Oral	3.3%
266	Paraneoplastic Cerebellar Degeneration	3.3%
267	Lymphatic Metastasis	3.3%
268	Neoplasms, Unknown Primary	3.3%
269	Leukemic Infiltration	3.3%
270	Breast Neoplasms, Male	3.3%
271	Neoplasm Micrometastasis	3.3%
272	Triple Negative Breast Neoplasms	3.3%
273	Adrenocortical carcinoma	3.2%
274	Gastrinoma	3.1%
275	Glucagonoma	3.1%
276	Mycosis Fungoides	3%
277	Lymphomatoid Papulosis	3%
278	Plasmablastic lymphoma	3%
279	Nasopharyngeal carcinoma	2.9%
280	Leydig Cell Tumor	2.9%
281	Esophageal Neoplasms	2.7%
282	Renal Cell Carcinoma	2.7%
283	Papillary Renal Cell Carcinoma	2.7%
284	Limbic Encephalitis	2.7%
285	Thyroid Nodule	2.6%
286	Carcinoma, Endometrioid	2.6%
287	Adrenal Gland Neoplasms	2.6%
288	Gastrointestinal Neoplasms	2.6%
289	Genital Neoplasms, Male	2.6%
290	Liver neoplasms	2.6%
291	Uveal Neoplasms	2.6%
292	Denys-Drash Syndrome	2.5%
293	Urologic Neoplasms	2.5%
294	Sebaceous Gland Neoplasms	2.5%
295	Spinal Neoplasms	2.5%
296	Bone Marrow Neoplasms	2.5%
297	Polycystic Ovary Syndrome	2.4%
298	Burkitt Lymphoma	2.4%
299	Lambert-Eaton Myasthenic Syndrome	2.4%
300	Testicular Neoplasms	2.4%
301	Meningeal Neoplasms	2.2%
302	Opsoclonus-Myoclonus Syndrome	2.1%
303	Sezary Syndrome	2%
304	Xeroderma Pigmentosum	1.9%
305	Myelitis, Transverse	1.8%
306	Ear Neoplasms	1.7%
307	Eyelid Neoplasms	1.7%
308	Lung Neoplasms	1.7%
309	Nose Neoplasms	1.7%
310	Pleural Neoplasms	1.7%
311	ovarian neoplasm	1.7%
312	Cell Transformation, Viral	1.6%
313	Brain Neoplasms	1.6%
314	Salivary Gland Neoplasms	1.6%
315	Spinal Cord Neoplasms	1.6%
316	Tongue Neoplasms	1.6%
317	Palatal Neoplasms	1.6%
318	Uterine Neoplasms	1.6%
319	Vaginal Neoplasms	1.6%
320	Vulvar Neoplasms	1.6%
321	Uterine Cancer	1.6%
322	Fallopian Tube Neoplasms	1.6%
323	Meningeal Carcinomatosis	1.6%
324	Pituitary Adenoma	1.5%
325	Pituitary Neoplasms	1.5%
326	Pharyngeal Neoplasms	1.4%
327	Central Nervous System Cysts	1.3%
328	Bile Duct Neoplasms	1.3%
329	gallbladder neoplasm	1.3%
330	Intestinal Neoplasms	1.3%
331	Penile Neoplasms	1.3%
332	Prostatic Neoplasms	1.3%
333	Stomach Neoplasms	1.3%
334	Polycythemia Vera	1.3%
335	Bronchial Neoplasms	1.2%
336	Zollinger-Ellison syndrome	1.2%
337	Multiple Pulmonary Nodules	1.2%
338	Supratentorial Neoplasms	1.2%
339	Endometrial Neoplasms	1.2%
340	Laryngeal neoplasm	1.1%
341	Bladder Neoplasm	1.1%
342	Kidney Neoplasm	1.1%
343	Ureteral Neoplasms	1.1%
344	Urethral Neoplasms	1.1%
345	Brain Stem Neoplasms	1%
346	Hypopharyngeal Neoplasms	1%
347	Pleural Effusion, Malignant	1%
348	Hypopharyngeal Cancer	1%
349	Parotid Neoplasms	1%
350	Prostatic Neoplasms, Castration-Resistant	1%
351	Nelson Syndrome	1%
352	Choroid Plexus Papilloma	0.9%
353	Cecal Neoplasms	0.8%
354	Duodenal Neoplasms	0.8%
355	Tonsillar Neoplasms	0.8%
356	Cerebellar Neoplasms	0.8%
357	Nasopharyngeal Neoplasms	0.7%
358	Colorectal Neoplasms	0.7%
359	Radicular Cyst	0.7%
360	Appendiceal Neoplasms	0.7%
361	Colonic Neoplasms	0.7%
362	Rectal Neoplasms	0.7%
363	Paranasal Sinus Neoplasms	0.6%
364	Anus Neoplasms	0.5%
365	Sigmoid Neoplasms	0.5%
366	Maxillary Sinus Neoplasms	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234